Front. Cell Dev. Biol., 2021 · DOI: 10.3389/fcell.2021.688789 · Published: August 27, 2021
Mitochondria, the energy centers of cells, participate in epigenetic regulation of neurodegenerative diseases. Mitochondria can influence nuclear epigenome using metabolites like acetyl-CoA and NAD+. Abnormal modification of mitochondrial DNA contributes to disease development via mitochondrial dysfunction.
Targeting mtDNA methylation may offer therapeutic strategies for neurodegenerative diseases.
Fluctuations in mtDNA methylation levels could serve as epigenetic biomarkers for neurodegenerative diseases.
Further research is required to research and development of mitochondria-specific drugs.